Vivazome Therapeutics

VivaZome Therapeutics Pty Ltd is a privately-held Australian biotech company, with operational headquarters at the Bio Innovation Hub at La Trobe University in Melbourne, Australia. VivaZome is developing and will commercialise customised EV-based therapies for debilitating and life-threatening disorders, with a focus on neurological conditions, especially Traumatic Brain Injury and associated Post-Traumatic Epilepsy, stroke and dementia. VivaZome is developing new technologies, intellectual property and manufacturing processes that apply generically to EV therapies. These underpin the Company’s development of specific EV products for its target indications. The VivaZome team has extensive expertise in the development and commercialisation of biological therapies, together with a wide network of expert contacts in the Australian and global biotech communities. VivaZome acknowledges the support of the Department of Industry and Science through the CRC-P program, and the contribution of its CRC-P partners: University of Queensland, La Trobe University, Cytiva and SeerPharma Pty Ltd. For more information, please visit